First Time Loading...

Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 5.88 USD 0.51% Market Closed
Updated: May 7, 2024

Collplant Biotechnologies Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Collplant Biotechnologies Ltd
Revenue Peer Comparison

Comparables:
KMDA
B
BLRX
URGN
ENTX
B
BONS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Revenue
$11m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Revenue
$142.5m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
B
BioLine RX Ltd
TASE:BLRX
Revenue
$4.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Revenue
$82.7m
CAGR 3-Years
91%
CAGR 5-Years
136%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Revenue
₪0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Collplant Biotechnologies Ltd
Revenue Breakdown

Breakdown by Geography
Collplant Biotechnologies Ltd

Total Revenue: 11m USD
100%
United States: 10.8m USD
98.9%
Canada: 87k USD
0.8%
Europe And Other: 28k USD
0.3%
Israel: 5k USD
0%
Show More
Show Less

Breakdown by Segments
Collplant Biotechnologies Ltd

Not Available

See Also

What is Collplant Biotechnologies Ltd's Revenue?
Revenue
11m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Revenue amounts to 11m USD.

What is Collplant Biotechnologies Ltd's Revenue growth rate?
Revenue CAGR 5Y
17%

Over the last year, the Revenue growth was 3 553%. The average annual Revenue growth rates for Collplant Biotechnologies Ltd have been 21% over the past three years , 17% over the past five years .